登入 加入會員 求助
 
Sichuan Kelun Bio-Tech Pharmaceutical Co., Ltd.
 
 
Recommended Results 
 
Meningococcal Vaccine 

  產品分類 : 化學->藥品->牛痘

     
Meningococcal Vaccine
       

  產品規格
 
Model No:    5
  Country  CN
  Payment Term  T/T, L/C

 

  產品描述
   
  Drug Name:
Meningococcal Vaccine
General Information:
Meningococcal meningitis caused by the bacterium Neisseria meningitides, is a serious infection of the fluid in the spinal cord and the fluid that surrounds the brain and can result in brain damage and even death.
The bacteria are spread by direct close contact with the discharges from the nose or throat of an infected person.
Meningococcal meningitis is most common in infants and children. People who have had close or prolonged contact with a patient with meningococcal meningitis are at increased risk.
Bacterial meningitis can be treated with antibiotics, but an early diagnosis and treatment is crucial.
To prevent the disease, vaccines are the best choice.
The vaccine against meningitis consists of highly purified polysaccharides that originate from the Meningococcal bacteria. Currently vaccines are produced against 4 serotypes, called A, C, Y and W135. The strains used for production are recommended by WHO/NICPBP and provided by NICPBP.
The production of Meningococcal vaccine starts with the passaging of the seed strain on solid medium and moves on to the inoculation and propagation in 60 L and for the final fermentation in 600 L.
After harvesting and inactivation of the meningococcal bacteria, the polysaccharide is extracted and purified performing different downstream operations. These production steps are applied separately for each of the four meningococcal strains.
Tianyuan produces 3 types of polysaccharide meningitis vaccines: one mono-valent: Men A, one di-valent: Men AC, and one tetra-valent: Men ACYW135 which are filled into vials and lyophilized in freeze-dryers. Tianyuan also provides the reconstitution solution. This process allows an excellent shelf-life of the product. Finally, the vaccine quality is checked and then marketed after approval by the national regulatory authority (SFDA).
For the future it is planned to provide multi-dose vials of Men AC PS vaccine to meet national and international market requirements.
In China serotype A and C are prevalent, however the Men ACYW135 PS vaccine is the best choice to get vaccinated.
Tianyuan's Meningococcal Polysaccharide Vaccine YUNAONING is available as divalent (AC) or quadrivalent (ACYW135) formulation by the 2008. The vaccines consists of highly purified polysaccharides of the different meningococcal serogroups.
Although mostly serogroups A and C are prevalent in China, the quadrivalent vaccine provides additional protection. Both vaccines are high-quality vaccines. Tianyuan aspires to get the WHO-prequalification for its vaccines.


   


[ Back Products Catalog ]

Commerce 會員:
請登入您的 帳號 跟 密碼, 系統將自動為您填入您的相關基本資料!
 
帳號:
密碼:
記住我的帳號
 
 
填寫下列表格並寄送詢問函.所有的詢問信函將會自動寄發給你想聯絡的公司
主旨
內容 ﹙ 請勿輸入公司名稱、Email、電話、傳真、網址 ﹚
   

 


公司簡介:

*公司名稱
*E-mail
*國家
*聯絡人
網址
*電話
- -
傳真
- -
*郵遞區號
*城市
*街道地址
*企業形態
批發商   出口商 進口商 製造商
大盤商 零售商  代理商 Retrofitter 使用者
其他, 請詳細說明:
*安全密碼
請輸入所顯示的安全密碼


網站導覽 l 隱私權政策 l 服務團隊 l 合作提案 l 聯絡我們 l 幫幫我 l 廣告刊登 l  B2B商業夥伴
    .